<DOC>
	<DOCNO>NCT00869375</DOCNO>
	<brief_summary>The purpose study compare effect ( positive negative ) two different device available treat people critical limb ischemia , involve sudden decrease blood flow leg cause potential threat limb cause pain rest , ulcer gangrene . One device Clearway balloon , delivers drug dissolve clot blockage . The device Angiojet , remove clot mechanical way ( `` vacuum '' effect ) . This research do currently single proven effective treatment condition . Even though , device commonly use clinical practice treat critical limb ischemia , study compare device help u see one may better patient .</brief_summary>
	<brief_title>Use Clearwayâ„¢ Balloon v . Mechanical Thrombectomy Initial Treatment Acute Limb Ischemia</brief_title>
	<detailed_description>This prospective randomized clinical trial patient peripheral vascular disease acute subacute arterial thrombosis compare percutaneous transluminal angioplasty simultaneous situ thrombolysis use Clearway balloon system mechanical thrombectomy Angiojet system . Main endpoint time successful revascularization , frequency distal embolization incidence bleed complication .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Adults 18 85 year age Diagnosis acute limb ischemia ( define abrupt onset low extremity pain loss peripheral pulse absent Doppler pulse least one artery and/or ultrasonographic evidence decrease absent blood flow affect limb ) Diagnosis critical limb ischemia ( define rest low extremity pain ABI &lt; 0.4 and/or ultrasonographic evidence decrease absent blood flow affect limb ) . Angiographic confirmation thrombus . Need intervention within 21 day onset symptom Any contraindication thrombolytic therapy ABSOLUTE CONTRAINDICATIONS : A . Any history intracranial hemorrhage ; recent ( within three month ) hemorrhagic cerebrovascular accident ( CVA ) / transient ischemic attack ( TIA ) significant close head facial injury . B . Known intracranial neoplasm arteriovenous malformation . C. Suspected aortic dissection . D. Active bleed diathesis hemostatic defect : ( Excluding menses ) ; active internal RELATIVE CONTRAINDICATIONS : Fibrinolytic therapy may use presence condition upon clinical assessment treatment dependent upon bleed risk : A . History chronic , severe , poorly control blood pressure Severe uncontrolled hypertension presentation ( SBP &gt; 180 , DBP &gt; 110 ) . B . History prior ischemic stroke ( great 3 month ) dementia , know intracranial pathology cover absolute contraindication . C. Traumatic prolong CPR ( &gt; 10 minute ) , major surgery ( &lt; 3 week ) , recent trauma , include head trauma ( 24 week ) . D. Recent ( within 2 4 week ) internal bleeding . E. Noncompressible vascular puncture . F. Pregnancy recent obstetrical delivery . G. Active peptic ulcer disease . H. Anticoagulant use ( INR &gt; 23 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>acute critical limb ischemia angiographic thrombus</keyword>
</DOC>